Dr. Emilia Liana Falcone is the Director of the IRCM Post-COVID-19 research clinic and Microbiome and Mucosal Defense Research Unit at the Montreal Clinical Research Institute (IRCM). She is also an Assistant Clinical Professor at Université de Montréal, an infectious diseases specialist at Centre Hospitalier de l'Université de Montréal, and holds a Canada Research Chair in the Role of the Microbiome in Primary Immunodeficiency.
Dr. Falcone studied medicine at McGill University and spent 8 years at the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH), where she completed a fellowship in Infectious Diseases and obtained a Ph.D. at the University of Cambridge (NIH-Oxford-Cambridge scholarship). During the COVID-19 pandemic, Dr. Falcone established the IRCM Post-COVID-19 (IPCO) research clinic, the first clinic of its kind in Quebec, and has since evaluated hundreds of patients with long-term COVID-19. Dr. Falcone is a member of the Long COVID Web and Biobanque Quebecoise de la COVID-19 (BQC19) steering committees and co-leads the Long COVID Web Biomedical Pillar; she has also collaborated on several provincial and federal long COVID initiatives.